Newer Breast Cancer Drugs May Carry Higher Risk of Heart Problems Than Tamoxifen: Study
"Treatment with aromatase inhibitors is associated with a significant increase in the risk of cardiovascular events, specifically heart attacks, angina, and heart failure, compared with tamoxifen," says Eitan Amir, MD, a senior fellow in oncology and hematology at the Princess Margaret Hospital in Toronto.
And in December 2008, the FDA added a warning label to Arimidex cautioning of the increased risk for heart disease, he says.
Src: https://www.webmd.com/breast-cancer/...se-heart-risks
"Treatment with aromatase inhibitors is associated with a significant increase in the risk of cardiovascular events, specifically heart attacks, angina, and heart failure, compared with tamoxifen," says Eitan Amir, MD, a senior fellow in oncology and hematology at the Princess Margaret Hospital in Toronto.
And in December 2008, the FDA added a warning label to Arimidex cautioning of the increased risk for heart disease, he says.
Src: https://www.webmd.com/breast-cancer/...se-heart-risks
Comment